CJC/IPAMORELIN

CJC-1295 and Ipamorelin are synthetic peptides designed to stimulate growth hormone (GH) release from the pituitary gland. CJC-1295, a growth hormone-releasing hormone (GHRH) analog, triggers sustained GH production, while Ipamorelin, a selective ghrelin mimetic, prompts rapid GH pulses. Together, they amplify GH levels up to 5 times more effectively than Ipamorelin alone, with minimal impact on other hormones like cortisol or prolactin, making them a targeted and efficient choice for hormone optimization.

This peptide combination delivers a wide range of benefits for fitness, recovery, and anti-aging. Users may experience enhanced muscle growth through improved protein synthesis, accelerated fat loss via increased lipolysis, faster recovery from workouts or injuries, and anti-aging effects like better skin elasticity and energy. Additionally, many report improved sleep quality, which supports overall health and cognitive function, making this therapy a versatile option for wellness-focused individuals.

CJC-1295 promotes prolonged GH release with a half-life of 6-8 days, ensuring steady hormone elevation. Ipamorelin complements this by triggering immediate GH spikes through ghrelin receptor activation. Typically administered via subcutaneous injections, often at night to align with the body’s natural GH rhythm, this duo optimizes growth hormone output. Dosages (e.g., 100-300 mcg per peptide) are tailored to individual needs, and treatment requires medical supervision to ensure safety and efficacy. Always consult a healthcare provider to determine if this therapy is right for you.